Technology platform licensing
Licensing opportunities available
iCRT-deter offers a platform solution for the controlled release of potent and addictive compounds, including opioids. With abuse deterrent properties, and tailored release of active ingredients, iCRT-deter can help protect the patient and the product.
Partnering with Lucideon will offer:
- Formulation consultancy and development trials.
- Access to licensing rights.
- Product IP extension.
Through decades of partnership and collaboration we’ve learned that nothing accelerates R&D better than working together, and Lucideon adds value through partnership in more ways than one.
Partnering – innovation through collaboration:
- Exploit novel technology platforms.
- Focus your R&D.
- Accelerate your time to market.
- Boost your organization’s innovation.